Zhuoyibio

Founded on Jan. 27th, 2005, Zhuoyi Bio is with a registered capital of 95.08 million yuan and a total area of square meters. It has leading domestic vaccine research and development and production capabilities. Zhuoyi Bio devotes itself to the R&D, manufacture, and sale of new-type vaccines. The biological product currently approved in the company is Freeze-dried Rabies Vaccine (Vero Cell) for Human Use. Zhuoyi Bio successfully passed the two-in-one inspection and obtained registration approval and GMP certificate at the end of 2016. Officially put into production in Jan. The company's existing workshop covers an area of approximately 5,700 square meters, with a total investment of 300 million yuan, and a maximum annual output of 1 million copies. The second-phase workshop was completed at the end of 2017, with a production capacity of 4 million people. Zhuoyi Bio has nearly square meters of pilot research workshops, including bioreactors, ultrafiltration systems, AKTA purification workstations, fluorescence microscopes, and other advanced equipment for virus cultivation, purification system improvement, and the identification of recombinant proteins. Our company maintains close scientific research cooperation relationships with several research institutes at home and abroad. Currently, our cooperating projects include human papillomavirus 16/18/58/52 tetravalent vaccines, new compound adjuvant rabies vaccines, rotavirus vaccines, and other R&D projects. Zhuoyi Bio invites all enterprises on biologics R&D, manufacturing, and marketing at home and abroad for sincere cooperation and mutual development. For any detailed information, please consult: Tel+86-(0) 0431-84153900 E_mail meghamao@yahoo.com Fax+86-(0) 0431-84153600